(Q34481510)

2 August 2017

1 reference

title

Aminolevulinic acid: pharmacological profile and clinical indication (English)

1 reference

2 August 2017

1 reference

1 reference

Lang K

1

1 reference

2 August 2017

Lehmann P

2

1 reference

2 August 2017

Bolsen K

3

1 reference

2 August 2017

Ruzicka T

4

1 reference

2 August 2017

Fritsch C

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

10

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

1139-1156

1 reference

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Management of superficial bladder cancer: what is new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Laparoscopic radical and partial nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Margin status and excision of cervical intraepithelial neoplasia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Photodynamic therapy in oncology: mechanisms and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Effects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumour tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Hemodynamic effects of 5-aminolevulinic acid in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Photodynamic therapy: a better treatment for widespread Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral delta-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Successful surgery of multiple recurrent basal cell carcinomas guided by photodynamic diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Carbon dioxide laser treatment of extramammary Paget's disease guided by photodynamic diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

[Visualizing carcinomas of the mouth cavity by stimulating synthesis of fluorescent protoporphyrin IX].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Topical ALA-photodynamic therapy for the treatment of acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Treatment of viral infections with 5-aminolevulinic acid and light

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Fluorescence detection of bladder tumors with 5-amino-levulinic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Topical aminolevulinic acid HCl photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Expression kinetics of the (proto) oncogenes c-myc and bcl-2 following photodynamic treatment of normal and transformed human fibroblasts with 5-aminolaevulinic acid-stimulated endogenous protoporphyrin IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.6.1139

10.1517/13543784.10.6.1139

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference